Cardiff Oncology, Inc. (FRA:XE7C)
Germany
· Delayed Price · Currency is EUR 1.750
+0.076 (4.54%)
At close: Dec 4, 2025
Cardiff Oncology Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -50.42 | -45.43 | -41.44 | -38.7 | -28.29 | -19.31 | Upgrade
|
| Depreciation & Amortization | 0.37 | 0.4 | 0.4 | 0.24 | 0.45 | 0.47 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | 0 | 0 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 0.03 | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.85 | -0.6 | -0.92 | 0.63 | 1.61 | - | Upgrade
|
| Stock-Based Compensation | 5.64 | 4.76 | 4.51 | 4.26 | 3.23 | 1.77 | Upgrade
|
| Other Operating Activities | - | - | - | 0.14 | 1.75 | 1.38 | Upgrade
|
| Change in Accounts Receivable | 0.37 | -0.48 | 0.48 | -0.24 | -0.22 | -0.12 | Upgrade
|
| Change in Accounts Payable | 2.16 | 2.99 | 2.83 | 1.35 | 0.72 | 1.28 | Upgrade
|
| Change in Other Net Operating Assets | 0.51 | 0.67 | 3.25 | -1.49 | -2.29 | -1.81 | Upgrade
|
| Operating Cash Flow | -42.22 | -37.69 | -30.89 | -33.82 | -23.04 | -16.32 | Upgrade
|
| Capital Expenditures | -0.04 | -0.08 | -0.58 | -1.01 | -0.21 | -0.21 | Upgrade
|
| Investment in Securities | -4.85 | 13.81 | 36.78 | 39.04 | -131.24 | - | Upgrade
|
| Other Investing Activities | - | - | - | 0.11 | - | - | Upgrade
|
| Investing Cash Flow | -4.9 | 13.73 | 36.2 | 38.15 | -131.45 | -0.21 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 0.31 | Upgrade
|
| Total Debt Issued | - | - | - | - | - | 0.31 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -0.31 | Upgrade
|
| Total Debt Repaid | - | - | - | - | - | -0.31 | Upgrade
|
| Issuance of Common Stock | 44.22 | 53.78 | - | 0.08 | 36.26 | 144.83 | Upgrade
|
| Other Financing Activities | - | - | - | - | -0.81 | -7.52 | Upgrade
|
| Financing Cash Flow | 44.22 | 53.78 | - | 0.08 | 35.45 | 137.31 | Upgrade
|
| Net Cash Flow | -2.9 | 29.82 | 5.31 | 4.4 | -119.04 | 120.79 | Upgrade
|
| Free Cash Flow | -42.27 | -37.77 | -31.47 | -34.83 | -23.25 | -16.53 | Upgrade
|
| Free Cash Flow Margin | -8436.53% | -5530.45% | -6448.57% | -9022.28% | -6474.93% | -4515.30% | Upgrade
|
| Free Cash Flow Per Share | -0.67 | -0.79 | -0.70 | -0.80 | -0.60 | -0.79 | Upgrade
|
| Cash Income Tax Paid | - | - | - | 0 | 0 | 0 | Upgrade
|
| Levered Free Cash Flow | -24.98 | -23.07 | -18.01 | -21.04 | -16.74 | -9.78 | Upgrade
|
| Unlevered Free Cash Flow | -24.98 | -23.07 | -18.01 | -21.04 | -16.74 | -9.78 | Upgrade
|
| Change in Working Capital | 3.04 | 3.17 | 6.57 | -0.38 | -1.79 | -0.65 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.